Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-24

Clinical Trial Update: A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma [Phase 4]

View source ↗

Summary

This is an ongoing Phase 4 clinical trial evaluating oral semaglutide in people with open-angle glaucoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oral semaglutide (semaglutide)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Primary Open Angle Glaucoma (POAG), Open-Angle Glaucoma | Phase 4 | Status: RECRUITING